This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen acción ANHG.Y
Mediclinic International plc, together with its subsidiaries, operates private hospitals.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Mediclinic International plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£5.49 |
| 52 Week High | UK£5.58 |
| 52 Week Low | UK£5.49 |
| Beta | 0.48 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -59.69% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| ANHG.Y | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 0% | -3.4% | -1.7% |
| 1Y | n/a | -5.6% | 22.4% |
Rentabilidad vs. Industria: Insufficient data to determine how ANHG.Y performed against the US Healthcare industry.
Rentabilidad vs. Mercado: Insufficient data to determine how ANHG.Y performed against the US Market.
Volatilidad de los precios
| ANHG.Y volatility | |
|---|---|
| ANHG.Y Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: ANHG.Y has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine ANHG.Y's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1983 | 33,683 | Ronnie van der Merwe | www.mediclinic.com |
Resumen de fundamentos de Mediclinic International plc
| Estadísticas fundamentales de ANHG.Y | |
|---|---|
| Capitalización bursátil | US$4.08b |
| Beneficios(TTM) | US$169.25m |
| Ingresos (TTM) | US$3.62b |
24.1x
Ratio precio-beneficio (PE)1.1x
Ratio precio-ventas (PS)¿Está ANHG.Y sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ANHG.Y | |
|---|---|
| Ingresos | UK£3.23b |
| Coste de los ingresos | UK£2.53b |
| Beneficio bruto | UK£706.00m |
| Otros gastos | UK£555.00m |
| Beneficios | UK£151.00m |
Últimos beneficios comunicados
Mar 31, 2022
Próxima fecha de beneficios
Nov 16, 2022
| Beneficios por acción (BPA) | 0.20 |
| Margen bruto | 21.84% |
| Margen de beneficio neto | 4.67% |
| Ratio deuda/patrimonio | 55.6% |
¿Cómo se ha desempeñado ANHG.Y a largo plazo?
Ver rendimiento histórico y comparativa